CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem ® (invimestrocel) for critical care ...
The latest update is out from GeoVax Labs ( (GOVX)). On March 31, 2026, GeoVax Labs entered into a warrant inducement agreement with existing healthcare-focused institutional investors, who agreed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results